Navigation Links
Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy

throat, and nausea.

For Full Prescribing Information, please visit www.ORENCIA.com or www.bms.com

Dosing and Administration

ORENCIA is administered by a healthcare professional as a 30-minute intravenous infusion at a fixed dose based on body weight range approximating 10 mg/kg at day 0, 2 weeks, 4 weeks, and every 4 weeks thereafter. Acute infusion-related reactions were experienced in nine percent of people treated with ORENCIA and in six percent of people treated with placebo. According to the full prescribing information, the most frequently reported infusion- related adverse events (1 percent to 2 percent) were dizziness, headache, and hypertension. In pivotal studies, premedications were not required. However, appropriate medical support measures for the treatment of hypersensitivity reactions should be available for immediate use in the event of a reaction.

About Juvenile Idiopathic Arthritis

ORENCIA is not FDA-approved for use in children with juvenile idiopathic arthritis (JIA).

JIA - also commonly known as juvenile rheumatoid arthritis (JRA) - is a chronic, autoimmune disease, causing chronic pain, stiffness and swelling of the joints, which may ultimately lead to joint damage and deformities. The disease usually begins before the age of 16 and may affect up to 1 child in every 1,000 in the United States. Despite current therapies, some individuals with JIA experience ongoing disease and many eventually worsen, resulting in severe joint damage and abnormal joint function.

About ORENCIA(R) (abatacept)

ORENCIA is indicated in the United States for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... , May 22, 2015  Effective staffing ... pharmaceutical brand recognition and success. ... a study to provide pharmaceutical and biotech marketing ... (FTEs and budget) that are being channeled into ... biotech marketing managers can utilize this report to ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2
... 18, 2011 Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, ... evaluating the use of Nexavar® (sorafenib) tablets will be presented ... the American Society of Clinical Oncology (ASCO), June 3-7, in ... researching the potential utility of sorafenib, and the number of ...
... Laser ( www.XTRACLaser.com ) treatments, psoriasis patients can say ... skin they have been covering up all winter. Developed ... ), an innovator of medical devices, the XTRAC laser ... from this embarrassing and socially isolating disease. Broad coverage ...
Cached Medicine Technology:Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 2Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 3Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 4Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 5Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 6Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 7XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 2XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 3XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 4
(Date:5/23/2015)... Washington, D.C. (PRWEB) May 23, 2015 ... demonstration of powers of a youngster's yogic power learned ... by Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, ... of more than 50 high profile professionals attending the ... D.C. by reading fluently -- blindfolded. , In ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
(Date:5/23/2015)... A live auction will be held to sell over ... other medical facilities around the United States. Various types ... anesthesia, exam and much more. , The live auction ... starting at 9:00am CDT each day. The equipment is at ... Park, IL 60160. Anyone can participate in the auction ...
(Date:5/23/2015)... MD (PRWEB) May 23, 2015 Injury lawyer ... that has been passed by the Maryland legislature but which ... “The Maryland General Assembly passed HB 449 with ... Governor has not signed it into law. This bill ensures ... Evidence is growing that demonstrates the danger of fracking to ...
(Date:5/22/2015)... 2015 The American College of Traditional ... June. They will hold a webinar on the updates ... class on Classical Chinese Medicine. , Webinar – First ... Given, the Dean of Clinical Education, will lead this ... Professional Doctorate program. ACTCM is currently developing this degree ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:ACTCM Announces Upcoming June Events 2
... to Support Increasing Sales of the Company,s Innovative ... leader for charge capture technologies, today announced that ... a financing led by existing investor Boston Millennia ... support the growth of its Intelligent Charge Capture ...
... M.D., FSIR, delivered the 2009 Dr. Charles T. ... 34th Annual Scientific Meeting last week in San ... Foundation, honors an interventional radiologist,s extraordinary contributions to ... career achievements in interventional radiology. , Mauro, who ...
... lifestyles are just some of the barriers that stop ... according to a research review that covered 8,900 patients ... The study, published in the March issue of the ... , shows that psychosocial, socioeconomic, physical, environmental and cultural ...
... 19 Clinical Information Network, Inc., the Video ... has joined its board of directors.Until establishing his ... executive at Merck responsible for the successful deployment ... as well as being responsible for Merck,s Inside ...
... for World Water Day March 22 CHICAGO, March 19 ... testing services, will launch its water quality and conservation educational ... S. Lake Shore Drive in Chicago, from 10:00 a.m. to ... of the organization,s century-long commitment to public health and safety, ...
... Awards Cash Prizes To Winners In Gala EventSANTA MONICA, Calif., March ... of the year, Beachbody.com (developer of P90X(R) ) ... most dramatic fitness and weight loss transformations of the year. ... $250,000 each: , , , ...
Cached Medicine News:Health News:MedAptus Secures $6 Million Investment 2Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 2Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 3Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 4Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 3Health News:Former Merck Executive Joins Board of Clinical Information Network, Inc. 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 3Health News:Photos: Eight Finalists Lose 685 Pounds and Gain $800,000 2Health News:Photos: Eight Finalists Lose 685 Pounds and Gain $800,000 3Health News:Photos: Eight Finalists Lose 685 Pounds and Gain $800,000 4
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The SnuggleWarm Convective Warming provides the technology and the tools to effectively enhance the quality of patient care....
The product, which is comprised of a non-intrusive panty-liner, offers a simple to use classification tool that uses color identification for interpretation of the results....
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: